Associate Professor Tim Sprosen
Research groups
Websites
-
MoreTrials Campaign
Coordinator of campaign to make it much easier to do randomised trials
-
North-West (Haydock) NHS Research Ethics Committee
Chair
-
New York University Abu Dhabi
Member of International Advisory Committee for Abu Dhabi Cohort Study
Tim Sprosen
BSc(Hons) DPhil
Associate Professor & Head of Regulation & Knowledge Transfer
Tim Sprosen is an Associate Professor in the Nuffield Department of Population Health at the University of Oxford.
He studied Pharmacology at Dundee (1983-1987) and Cambridge (1987-1990).
He has spent his entire career in medical research in industry (Renal Division, Baxter Healthcare), public office (Medical Research Council Head Office) and in academia (Cambridge, Oxford, Manchester and Imperial College London). From 2004-2011, he was Chief Scientist at UK Biobank.
His main interests are in the design and execution of large-scale epidemiological studies, public participation in research, the use of health-records in research and promoting appropriate and proportionate governance of research.
He is leading a new public campaign, MoreTrials, working with leading trialists around the world and Sense About Science to make it much easier to do randomised trials. Its goal is to replace the ICH-Good Clinical Practice guideline (which is neither good or about clinical practice) with a new one that will focus on those few things that matter when doing a trial and which is developed by everybody in the trial community (including participants, who ICH still calls "subjects").
Recent publications
-
Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population.
Journal article
Fry A. et al, (2017), Am J Epidemiol, 186, 1026 - 1034
-
UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.
Journal article
Sudlow C. et al, (2015), PLoS Med, 12
-
New models for large prospective studies: is there a better way?
Journal article
Manolio TA. et al, (2012), Am J Epidemiol, 175, 859 - 866
-
UK Biobank: Current status and what it means for epidemiology
Journal article
Allen N. et al, (2012), Health Policy and Technology
-
Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies.
Journal article
Fortier I. et al, (2010), Int J Epidemiol, 39, 1383 - 1393